Results 151 to 160 of about 7,499 (195)

Late Reverse Pupillary Block After Scleral Fixation With Yamane Technique: A Case Report. [PDF]

Case Rep Ophthalmol Med
Chaves-Samaniego MJ, Awatramani G, Hussain N.   +2 more
europepmc   +1 more source

Usefulness of Measuring Corneal Stiffness in Predicting the Reduction of Intraocular Pressure With Microhook Ab Interno Trabeculotomy. [PDF]

Transl Vis Sci Technol
Asaoka K, Fujino Y, Fukuyo H, Murata H, Aoki S, Ishii K, Kiuchi Y, Asaoka R.   +7 more
europepmc   +1 more source

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial. [PDF]

J Clin Med
Kim M, Lee CK, Shin J, Kim D, Rho S.
europepmc   +1 more source

Periorbital skin hypopigmentation associated with the use of topical glaucoma medications. [PDF]

Digit J Ophthalmol
Karimaghaei S, Yee J, Elhusseiny AM.
europepmc   +1 more source

New Insights into Glaucoma-An Editorial Review on Broadening Risk Assessment, Refining Surgical Strategy, and Standardizing Clinical Practice. [PDF]

J Clin Med
Lim SH, Laroche D.
europepmc   +1 more source

Laser Iris Depigmentation Resulting in Markedly Elevated Intraocular Pressure and Herpes Simplex Keratitis with Corneal Scarring: Case Report. [PDF]

Case Rep Ophthalmol
Jaber W, Nemet M, Waisbourd M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Brimonidine

2023
Brimonidine is a highly selective 2-adrenoceptor agonist that lowers intraocular pressure (IOP) by decreasing aqueous humor production and increasing aqueous humor outflow via the uveoscleral route. Brimonidine is used to treat glaucoma and other eye conditions.
Ahmed H, Bakheit, Ahmed M, Alomar, Hany, Darwish, Hamad M, Alkahtani   +3 more
openaire   +2 more sources